Home » Newsletters » BioWorld Science

BioWorld Science

July 6, 2000

View Archived Issues

Oral heparin plus delivery agent shows enhanced efficacy in a rat model of DVT

Antiparkinsonian activity of KW-6002 with dopamine D1 or D2 agonists or L-Dopa

New combination HCV therapy launched in Germany

Kosan receives NIH grant to develop novel immunosuppressants

AVI BioPharma begins phase II trials of Resten-NG

Antigenics commences first phase III trial of its Oncophage cancer vaccine

Abbott and Battelle sign license agreement for pulmonary therapeutics

Integrase inhibitor L-chicoric acid synergistic in anti-HIV combination therapy

Investigational PPAR-alpha and -gamma agonist prevents diabetic complications in ZDF rats

AltaRex establishes joint venture for OvaRex

Antihypertensive substance found in kumis kucing leaves in Java

Merz and Forest establish development and marketing collaboration for memantine

Ixion receives patent for oxalate-related disease technology

Incyte and Lilly to accelerate therapeutic protein development

Oncolytics Biotech reports preclinical results of Reolysin in bladder cancer

PowderJect continues to move forward with robust product pipeline

AstraZeneca reports phase II results for statin drug ZD-4522

Anti-HIV peptoid discovered at Novartis interacts with two different targets

Potent and selective dimeric peptide IL-5 antagonist identified by Affymax and Glaxo Wellcome

Antioxidant properties of novel ureidophenol derivative T-0970 reported

L-838417, a new GABA-A receptor ligand, inhibits anxiety without inducing sedation

Ibandronate reported useful for improving outcome following endoprosthetic implant

Hydrophilic somatostatin analogues for treatment or diagnosis of cancer described by Tulane U.

Aventis-Genentech collaboration focusing on treatments for bone diseases yields new compounds

New inhibitors of tyrosine kinases synthesized at Aventis useful for restenosis, etc.

Antibacterial and antiprotozoal azalides designed by Pfizer

Inhibitors of alphav integrins and their use disclosed by Celltech researchers

D-Pharm reveals results with prodrug approach to NSAIDs

Anticoagulants from Berlex act by inhibiting factor Xa

Popular Stories

23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Today's news in brief
BioWorld
BioWorld briefs for June 18, 2025.
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 18, 2025.
EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment
BioWorld Science
Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...